National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 183 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome



Case Details

This is page 6 out of 19

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 1324172 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: California  
Vaccinated:2021-04-12
Onset:2021-05-06
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-05-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: CSF glucose normal, CSF protein increased, CSF white blood cell count increased, Guillain-Barre syndrome, Magnetic resonance imaging spinal abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: May 14th: CSF (WBC 62, Total protein 851, glucose 71) , MRI spine: Diffuse enhancement of the cauda equina. This is a nonspecific finding and could be due to arachnoiditis, demyelinating conditions such as Guillain-Barre or chronic inflammatory demyelinating polyneuropathy, among other etiologies.
CDC Split Type:

Write-up: Guillen Barre


VAERS ID: 1346758 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Male  
Location: California  
Vaccinated:2021-05-05
Onset:2021-05-23
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Bell's palsy, CSF cell count normal, CSF protein increased, Dyskinesia, Extraocular muscle paresis, Eyelid function disorder, Facial paresis, Guillain-Barre syndrome, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Dyskinesia (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Periorbital and eyelid disorders (narrow), Ocular motility disorders (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Allergies: NKA
Diagnostic Lab Data: LUMBAR PUNCTURE WITH CSF ANALYSIS REVEALS ELEVATED PROTEIN WITH NORMAL CELL COU MRI BRAIN WITH SUBTLE ENHANCEMENT OF FACIAL NERVES BILATERALLY PER NEUROLOGY READ
CDC Split Type:

Write-up: 35 Y/O MALE WITH NO SIGNIFICANT PMH PRESENTED TO EMERGENCY ROOM WITH ACUTE DIFFICULTY WITH MOUTH MOVEMENTS STARTING 18 DAYS AFTER JNJ COVID VACCINE. REPORTS DIFFICULTY WHISPERING, SMILING, PREVENTING LIQUIDS FROM LEAKING WHILE EATING. PATIENT IS UNABLE TO WRINKLE FOREHEAD, HAS SIGNFICANT WEAKNESS OF EYE CLOSURE WITH INCOMPLETE EYE CLOSURE ON BOTH EYES. NEUROLOGY DIAGNOSED PATIENT WITH BILATERAL PERIPHERAL FACIAL NERVE PALSY THAT IS LIKELY DUE TO GUILLAIN-BARRE SYNDROME VARIANT.


VAERS ID: 1347443 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Female  
Location: Oregon  
Vaccinated:2021-03-10
Onset:2021-03-30
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: progesterone 200mg fish oil 1000mg vit d 5000 units
Current Illness: none
Preexisting Conditions: a fib
Allergies: morphine neurontin
Diagnostic Lab Data: SPINAL TAP, MRI
CDC Split Type:

Write-up: PT DEVELOPED GUILLAIN-BARRE 3 WEEKS AFTER VACCINATION


VAERS ID: 1347836 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-04-03
Onset:2021-04-14
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Axillary pain, Blood pressure increased, Blood test, Computerised tomogram, Electrocardiogram abnormal, Encephalitis, Facial paralysis, Fatigue, Groin pain, Guillain-Barre syndrome, Headache, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging head abnormal, Mastication disorder, Neuralgia, Pain in extremity, Ultrasound scan
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (narrow), Noninfectious meningitis (broad), Hypertension (narrow), Cardiomyopathy (broad), Demyelination (narrow), Hearing impairment (broad), Osteonecrosis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: I take a bunch of vitamins. I take an 81 mg baby aspirin, vitamin C 500mg, B-Complex, Ubiquinol, Co-Q-10 and D3 5000mg.
Current Illness: I did not have any other illnesses.
Preexisting Conditions: I do not have any chronic health conditions.
Allergies: I have no allergies.
Diagnostic Lab Data: I had a spinal tap, 2 MRI''s of my brain, CAT scans, ultrasounds and a lot of bloodwork.
CDC Split Type: vsafe

Write-up: Initially I experienced nerve pains across my body, including under both of my armpits, in my groin area, in my arms including my triceps, forearms and they were very sharp pains. Then I started to get a severe headache that was pretty constant. After multiple days, my face became paralyzed. I also experienced severe fatigue. This was over 10 days. Once paralysis happened we went to the Medical Center. I was treated with IVIG for many days and oral steroids. I was in the hospital for 6 days. I also experienced my BP spiking. I had an abnormal EKG. I''m still unable to chew properly. I was told that now I have Encephalitis and GBS (Gillian Barres syndrome).


VAERS ID: 1358035 (history)  
Form: Version 2.0  
Age: 44.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-05-07
Onset:2021-05-22
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / 1 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Immunology test, Lymphocyte count increased, Protein total increased
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: possible Lyme
Preexisting Conditions: anxiety
Allergies: pollen
Diagnostic Lab Data: LP 5/27. Patient had elevated protein with very mild lymphocytic pleocytosis in CSF. There was a presumptive positive Lyme test prior, which has not been confirmed. A repeat Lyme screen in the hospital was negative. The causality to the vaccine is not clear, but is plausible.
CDC Split Type:

Write-up: Guillain Barre syndrome.


VAERS ID: 1362667 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Illinois  
Vaccinated:2021-03-11
Onset:2021-03-11
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805 / 1 RA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 63 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: keppera and toamax
Current Illness: gallbladder removal march 1,2021
Preexisting Conditions: epilepsy
Allergies: none
Diagnostic Lab Data: lumbar Punturce
CDC Split Type:

Write-up: guillian barre Sydrome


VAERS ID: 1364621 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-04-08
Onset:2021-04-22
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-06-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 202A21A / 1 LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Asthenia, Guillain-Barre syndrome, Lumbar puncture abnormal, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: LP 5/20/2021
CDC Split Type:

Write-up: Patient started with paresthesia and weakness mid April. He was ultimately diagnosed with Guillain-Barre syndrome via lumbar puncture on May 20th after 3 ED visits and 2 hospitalizations.


VAERS ID: 1366784 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Anaphylactic reaction, Bell's palsy, Guillain-Barre syndrome, Thrombosis
SMQs:, Anaphylactic reaction (narrow), Peripheral neuropathy (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Hearing impairment (broad), Hypersensitivity (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210556206

Write-up: BELL''S PALSY; BLOOD CLOT; GUILLAIN BARRE SYNDROME; ANAPHYLAXIS; This spontaneous report received from a patient via a company representative (other manufacturer Pfizer ) concerned multiple patients. The patient height and weight was not reported .No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported)frequency one total , dose, start therapy date were not reported for prophylactic vaccination.The batch no was not reported ,The Company is unable to performed follow up to request batch /Lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced bell''s palsy, blood clot, guillain barre syndrome, and anaphylaxis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bell''s palsy, blood clot, guillain barre syndrome and anaphylaxis was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0. 20210556206-COVID-19 VACCINE AD26.COV2.S. Bell''s palsy, Blood clot, Guillain Barre syndrome. This events is considered unassessable. The events has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events. 20210556206-COVID-19 VACCINE AD26.COV2.S. Anaphylaxis. This event is labeled per RSI and is therefore considered potentially related.


VAERS ID: 1371564 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-05-12
Onset:2021-05-21
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-06-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Auditory disorder, Cervical spinal stenosis, Compression fracture, Guillain-Barre syndrome, Lumbar spinal stenosis, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Accidents and injuries (narrow), Demyelination (narrow), Hearing impairment (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: sildenafil prn
Current Illness: etoh use disorder, chronic pain
Preexisting Conditions: etoh use disorder, chronic pain
Allergies: none
Diagnostic Lab Data: MRI C/T/L spine w/ contrast (5/29/21): IMPRESSION: 1. Motion limited study. 2. No acute compression fracture. Multiple chronic compression fractures most pronounced at T2, T3, T7 and T11. 3. No suspicious marrow process. 4. Spinal cord appears normal, within the limits of motion artifact. Although motion artifact limits visualization there is probable mild to severe foraminal narrowing and mild central stenosis within the cervical spine as detailed above 5. No spinal canal stenosis or neural foraminal narrowing in the thoracic spine. 6. Multilevel degenerative changes in the lumbar spine most pronounced at L4-5 where there is moderate to severe spinal canal stenosis with effacement of the thecal sac. 7. Lower lumbar spine endplate marrow edema is likely degenerative. MRI IAC and brain w/ contrast (5/31/21): IMPRESSION: 1. Foci of enhancement measuring 2-3 mm at the fundi of the internal auditory canals extending to the geniculate ganglia. This could represent infectious/inflammatory etiology. No nodularity to suggest bilateral schwannomas. 2. There is abnormal enhancement the left cisternal trigeminal nerve. 3. The above enhancement is without nodularity. Infectious/inflammatory etiology is considered most likely, however neoplastic process is not entirely excluded and correlation is recommended with CSF. 4. Limited evaluation of the brain demonstrates no additional enhancement on motion degraded examination. No acute infarct or suspicious parenchymal FLAIR signal abnormality. 5. Additional findings as above. CSF confirmation
CDC Split Type:

Write-up: guilliane barre syndrome


VAERS ID: 1377954 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-04-07
Onset:2021-04-13
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-06-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 041A21A / UNK - / IM

Administered by: Public       Purchased by: ?
Symptoms: Blood glucose normal, Guillain-Barre syndrome, Lumbar puncture abnormal, Protein total increased, Red blood cell count increased, White blood cell count normal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: pantoprazole (PROTONIX) 40 mg Tablet, Delayed Release (E.C.) levothyroxine (SYNTHROID) 50 mcg Tablet ibuprofen (IBU) 800 mg Tablet amLODIPine (NORVASC) 5 mg Tablet lisinopriL (PRINIVIL) 10 mg Tablet cyclobenzaprine (FLEXERIL) 10 mg Tablet m
Current Illness: Gastroesophageal reflux disease Pelvic floor dysfunction Hyperlipidemia, mixed Hypothyroidism (acquired) Vitamin D deficiency Hyperkalemia Adenomatous polyp of colon H/O hemorrhoids Midline low back pain without sciatica Chronic idiopathic constipation Routine general medical examination at a health care facility Essential hypertension Osteopenia of multiple sites
Preexisting Conditions: Gastroesophageal reflux disease Pelvic floor dysfunction Hyperlipidemia, mixed Hypothyroidism (acquired) Vitamin D deficiency Hyperkalemia Adenomatous polyp of colon H/O hemorrhoids Midline low back pain without sciatica Chronic idiopathic constipation Routine general medical examination at a health care facility Essential hypertension Osteopenia of multiple sites
Allergies: HydrocodoneNausea and Vomiting Codeine
Diagnostic Lab Data: lumbar puncture was performed on 5/17/2021, and CSF analysis showed unremarkable cell count (WBCs 0, RBCs 14), glucose 71. Protein highly elevated to 145. Albumino-cytological dissociation. Hospitalization 5-2021
CDC Split Type:

Write-up: Guillain-Barre


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166